Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[CHANGES IN THE QUALITATIVE AND QUANTITATIVE COMPOSITION OF GUT MICROBIOTA IN RATS DURING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS].
Validation and interpretation of the Dutch version of the Multiple Sclerosis Neuropsychological Screening Questionnaire.
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.
Freedom from disease activity in multiple sclerosis.
Physical fitness assessment in multiple sclerosis patients: A controlled study.
[Possibilities of using the 2010 McDonald criteria for early diagnosis of multiple sclerosis.]
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis.
Tysabri screening test may be unreliable
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.
Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
A CB(1)/CB(2) receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin.
Polymorphism of Apo lipoprotein E gene and the risk of multiple sclerosis.
Balance exercise for persons with multiple sclerosis using Wii games: a randomised, controlled multi-centre study.
Systematic localization of common disease-associated variation in regulatory DNA.
Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
Review: the role of vitamin D in nervous system health and disease.
A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
Natalizumab treatment of progressive multiple sclerosis (NAPMS)
Effects of Topiramate on Dysaesthetic Pain in a Patient with Multiple Sclerosis.
Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes.
The recurrent Guillain-Barré syndrome: a long-term population-based study.
Orbital Doppler evaluation of blood flow velocities in optic neuritis.
Diffusion-weighted imaging characteristics of biopsy-proven demyelinating brain lesions.
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation.
Pages
« first
‹ previous
…
183
184
185
186
187
188
189
190
191
…
next ›
last »